Signia Therapeutics announces the nomination of a CEO

Signia Therapeutics announces the nomination of Dr. Philippe Personne as CEO, effective as of 1st of October. Dr. Personne graduated with a Doctorate in Pharmacy from Université de Lyon and cumulates more than 25 years of experience in the healthcare industry, mostly in the field of pharmaceutics and medical devices. He held several management positions, … Continue reading Signia Therapeutics announces the nomination of a CEO